Generalized myasthenia gravis (gMG) is an incapacitating, immunoglobulin G (IgG)-mediated neuromuscular disease that often causes patients to struggle with activities of daily living because of poor symptom control.1-6*
In a recent online survey assessing the burden of gMG1*:
87% of participants with self-identified gMG reported giving up at least some of their hobbies
68% of participants reported concern that gMG limitations hurt their relationships
61% of respondents reported worrying that their symptoms are getting worse despite their current management
22% of respondents strongly agreed that their current gMG management is controlling their symptoms
Results were based on a cross-sectional online survey study of 150 US adults with a self-reported diagnosis of gMG. The survey explored the gMG diagnosis process, burden of disease, and burden of treatment.
Learn more about the burden patients with gMG may experience.
References: 1. Muley S et al. Poster presented at: Annual Carrell-Krusen Neuromuscular Symposium; February 18-19, 2021. 2. Rødgaard A et al. Clin Exp Immunol. 1987;67(1):82-88. 3. Jacob S. Eur Neurol Rev. 2018;13(1):18-20. doi.org/10.17925/ENR.2018.13.1.18 4. Twork S et al. Health Qual Life Outcomes. 2010;8:129. doi:10.1186/1477-7525-8-129 5. Gilhus NE. N Engl J Med. 2016;375(26):2570-2581. doi:10.1056/NEJMra1602678 6. Behin A, Le Panse R. Neuromuscul Dis. 2018;5(3):265-277. doi:10.3233/JND-170294